Clinical characteristics and treatment of pulmonary tuberculosis with multiple serous cavity effusion
肺结核合并多浆膜腔积液的临床特点及治疗方法分析

摘要

目的 针对肺结核合并多浆膜腔积液的临床特点及治疗方法进行分析。方法 在本院2021年5月到2022年5月期间，随机选取34例在我院接受肺结核合并多浆膜腔积液治疗的患者进行回顾性研究，对上述患者开展临床诊断并选取其中17例采用HREZV联合激素治疗，记为观察组，另外17例采用常规HREZ抗结核治疗，记为对比组，对比两组患者治疗情况。结果 观察组患者治疗效率、肺功能康复以及血气指标改善情况明显优于对比组（p<0.05）。结论 肺结核合并多浆膜腔积液患者在临床上主要表现为浸润型肺结核和急性血行播散型肺结核，其发病位置既有单侧也有多侧，采用四联抗结核治疗效果明显优于常规抗结核治疗，临床症状改善良好。

Abstract

Objective: To analyze the clinical characteristics and treatment of pulmonary tuberculosis with multiple serous cavity effusion.
Methods: from May 2021 to may 2022 in our hospital, 34 patients with pulmonary tuberculosis combined with multiple serous cavity effusion were randomly selected for retrospective study. Clinical diagnosis was carried out on the above patients, and 17 of them were treated with HREZV combined with hormone, which was recorded as the observation group, and the other 17 were treated with conventional HREZ anti tuberculosis, which was recorded as the comparison group. The treatment situation of the two groups of patients was compared.
Results: the treatment efficiency, recovery of lung function and improvement of blood gas indexes in the observation group were significantly better than those in the control group (P < 0.05).
Conclusion  : the patients with pulmonary tuberculosis complicated with multiple serous cavity effusion are mainly manifested as infiltrative pulmonary tuberculosis and acute hematogenous disseminated pulmonary tuberculosis in clinic. The incidence position is both unilateral and multi lateral. The effect of quadruple antituberculosis treatment is significantly better than that of conventional antituberculosis treatment, and the clinical symptoms are improved.